| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13274* | 2021 |
| Malignant gliomas in adults PY Wen, S Kesari New England Journal of Medicine 359 (5), 492-507, 2008 | 4932 | 2008 |
| Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial R Stupp, S Taillibert, AA Kanner, S Kesari, DM Steinberg, SA Toms, ... Jama 314 (23), 2535-2543, 2015 | 1286 | 2015 |
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators G Gabriely, T Wurdinger, S Kesari, CC Esau, J Burchard, PS Linsley, ... Molecular and cellular biology 28 (17), 5369-5380, 2008 | 1126 | 2008 |
| Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence AD Norden, GS Young, K Setayesh, A Muzikansky, R Klufas, GL Ross, ... Neurology 70 (10), 779-787, 2008 | 986 | 2008 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 967 | 2017 |
| Transdifferentiation of glioblastoma cells into vascular endothelial cells Y Soda, T Marumoto, D Friedmann-Morvinski, M Soda, F Liu, H Michiue, ... Proceedings of the National Academy of Sciences 108 (11), 4274-4280, 2011 | 615 | 2011 |
| Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma KL Ligon, E Huillard, S Mehta, S Kesari, H Liu, JA Alberta, RM Bachoo, ... Neuron 53 (4), 503-517, 2007 | 587 | 2007 |
| First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma LM Liau, K Ashkan, DD Tran, JL Campian, JE Trusheim, CS Cobbs, ... Journal of translational medicine 16, 1-9, 2018 | 545 | 2018 |
| A review of persistent post-COVID syndrome (PPCS) B Oronsky, C Larson, TC Hammond, A Oronsky, S Kesari, M Lybeck, ... Clinical reviews in allergy & immunology 64 (1), 66-74, 2023 | 466 | 2023 |
| Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors H Wakimoto, S Kesari, CJ Farrell, WT Curry Jr, C Zaupa, M Aghi, T Kuroda, ... Cancer research 69 (8), 3472-3481, 2009 | 414 | 2009 |
| Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours MT Makale, CR McDonald, JA Hattangadi-Gluth, S Kesari Nature Reviews Neurology 13 (1), 52-64, 2017 | 387 | 2017 |
| Corticosteroids in brain cancer patients: benefits and pitfalls J Dietrich, K Rao, S Pastorino, S Kesari Expert review of clinical pharmacology 4 (2), 233-242, 2011 | 373 | 2011 |
| Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives A Mukherjee, AK Waters, P Kalyan, AS Achrol, S Kesari, VM Yenugonda International journal of nanomedicine, 1937-1952, 2019 | 370 | 2019 |
| Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors I Krop, T Demuth, T Guthrie, PY Wen, WP Mason, P Chinnaiyan, ... Journal of clinical oncology 30 (19), 2307-2313, 2012 | 349 | 2012 |
| Autoantigen discovery with a synthetic human peptidome HB Larman, Z Zhao, U Laserson, MZ Li, A Ciccia, MAM Gakidis, ... Nature biotechnology 29 (6), 535-541, 2011 | 349 | 2011 |
| Human glioma growth is controlled by microRNA-10b G Gabriely, M Yi, RS Narayan, JM Niers, T Wurdinger, J Imitola, KL Ligon, ... Cancer research 71 (10), 3563-3572, 2011 | 344 | 2011 |
| MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development JC Akers, V Ramakrishnan, R Kim, J Skog, I Nakano, S Pingle, J Kalinina, ... PloS one 8 (10), e78115, 2013 | 342 | 2013 |
| Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy PG Richardson, W Xie, C Mitsiades, AA Chanan-Khan, S Lonial, ... Journal of Clinical Oncology 27 (21), 3518, 2009 | 341 | 2009 |
| MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity NM Teplyuk, B Mollenhauer, G Gabriely, A Giese, E Kim, M Smolsky, ... Neuro-oncology 14 (6), 689-700, 2012 | 314 | 2012 |
